High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Delphine Rossille,M. Gressier,Diane Damotte,Delphine Maucort-Boulch,Céline Pangault,G. Semana,S. Le Gouill,C Haioun,Karin Tarte,Thierry Lamy,Noel Milpied,Thierry Fest

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

2014

Delphine Rossille
M. Gressier
Diane Damotte
Delphine Maucort-Boulch
Céline Pangault
G. Semana
S. Le Gouill
C Haioun
Karin Tarte
Thierry Lamy
Noel Milpied
Thierry Fest

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Keywords:

Cancer research
Lymphoma
Clinical trial
Diffuse large B-cell lymphoma
Biomarker (medicine)
Programmed cell death ligand 1
Medicine
Cancer
Multivariate analysis
Cohort
Bone marrow
Chemotherapy
Internal medicine
Pathology
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

236

Citations